Introduction: Stiff person syndrome is characterized by muscle rigidity that waxes and wanes along with concurrent spasms. The symptoms of the stiff-person syndrome were identical to those of oxaliplatin side effects.
Methods: This was a case report of a 65-year-old man who was diagnosed with stiff-person syndrome. He experienced pain with bleeding from the rectum. Screening tests were used to check foramphiphysin antibodies and electromyography. FNAC was done from the government hospital which was conclusive of metastasis. He was initiated on Capecitabine and Oxaliplatin protocol.
Results: During the hospital stay, he was treated with 1gm Methylprednisolone for 5 days and sequentially with immunoglobulin 2gm per day for 5 days, concomitantly Benzodiazepam was given 10mg three times a day for 3 days but later withdrawn as the patient started experiencing dizziness. He achieved no clinical benefit in neurological status. Eventually developed aspiration pneumonia and succumbed to death after one month of diagnosis of SPS.
Conclusion: Further studies should carry out to develop an evidence-based approach to diagnosing and treating SPS patients.
Periodicity | Biannually |
Issue-1 | May |
Issue-2 | November |
ISSN Print | 2321-2217 |
ISSN Online | 2321-2225 |
RNI No. | CHAENG/2013/50088 |
Publisher's policy of the journal at Sherpa UK for the submitted, accepted, and published articles. Click OAPolicy
Plan-S ComplianceTo check compliance, one has to use the Journal Check Tool (JCT). This tool provided by cOAlition S (European funders) for the researchers (fundee) to check the compliance with the journal.
Recommend journal to your libraryYou can recommend the journal being a researcher or faculty member to your library. We will post a copy of the Journal to your library on your behalf at free of cost.
Click here: Recommend Journal
The authors are encouraged to submit the author’s copy (preprint) to appropriate preprint archives e.g. https://arxiv.org and/or on https://indiarxiv.org or institutional repositories (e.g., D Space) before paper acceptance by the editor of Journal. After publications of the paper author(s) should mention the citation information, title and abstract along with DOI number of the publication carefully on the required page of the depository(ies).
Contact: Phone: +91-172-2741000, +91-172-4691800
Email : editor.jptrm@chitkara.edu.in;
This work is licensed under a Creative Commons Attribution 4.0 International License.
View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode
View Licence Deed here https://creativecommons.org/licenses/by/4.0/
Journal of Pharmaceutical Technology, Research and Management by Chitkara University Publications is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://jptrm.chitkara.edu.in//
India’s top rated university
Chandigarh-Patiala National Highway, Punjab 140 401
Chandigarh Information Center SCO 160-161, Sector 9-C, Chandigarh 160 009
Chitkara University Publications,
Administrative Office, Saraswati Kendra, P.O. Box No. 70,
SCO 160-161, Sector- 9C, Chandigarh-160009, India
Email: chitkarauniversitypublications@chitkara.edu.in
Chitkara University Publications,
Centre for Research Impact and Outcome (CRIO),
Darwin Block, 4th Floor, Rajpura, Punjab – 140401, India
Phone: +01762507084
For journal please visit the website: https://jptrm.chitkara.edu.in/
The "Journal of Pharmaceutical Technology, Research and Management” is a peer-reviewed, refereed, bi-annual open-access Journal of "Chitkara University Publications".
ISSN (p): 2321-2217 ; ISSN (e): 2321-2225 ; RNI No: CHAENG/2013/50088